Sopan Pharmaceuticals Limited Issuing IPO Shares to Nepalese Employed Abroad From Chaitra 09
Summary
Sopan Pharmaceuticals Limited has announced an IPO issuance opening from 9th Chaitra for Nepalese citizens working abroad, offering 4,29,000 shares reserved specifically for them. The company manufactures generic and cephalosporin drugs in Lalitpur, Nepal.
Key Points
- Sopan Pharmaceuticals Limited is issuing IPO shares to Nepalese citizens working abroad from 9th to 12th Chaitra with a possible extension till 23rd Chaitra.
- The company’s total issued capital is Rs. 1.71 Arba, with 25% of shares (42,90,000 units) offered to the public.
- Out of public shares, 10% (4,29,000 units) are reserved exclusively for Nepalese diaspora abroad.
- CARE Ratings Nepal Limited upgraded Sopan Pharmaceuticals Limited’s issuer rating to CARE-NP B (Is), indicating high default risk.
- NMB Capital Limited is the issue manager for this public offering.
